Sotera Health Co. (SHC)
19.54
+0.03
(+0.15%)
USD |
NASDAQ |
Aug 26, 16:00
19.54
0.00 (0.00%)
After-Hours: 16:06
Sotera Health Debt to Equity Ratio : 3.407 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.407 |
| March 31, 2026 | 3.647 |
| December 31, 2025 | 3.752 |
| September 30, 2025 | 4.137 |
| June 30, 2025 | 4.596 |
| March 31, 2025 | 5.667 |
| December 31, 2024 | 5.805 |
| September 30, 2024 | 5.014 |
| June 30, 2024 | 5.552 |
| March 31, 2024 | 5.464 |
| December 31, 2023 | 5.244 |
| September 30, 2023 | 6.164 |
| June 30, 2023 | 5.557 |
| March 31, 2023 | 6.436 |
| Date | Value |
|---|---|
| December 31, 2022 | 5.802 |
| September 30, 2022 | 3.021 |
| June 30, 2022 | 2.888 |
| March 31, 2022 | 2.844 |
| December 31, 2021 | 3.119 |
| September 30, 2021 | 3.475 |
| June 30, 2021 | 3.670 |
| March 31, 2021 | 4.148 |
| December 31, 2020 | 4.221 |
| September 30, 2020 | -4.506 |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -4.433 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Ginkgo Bioworks Holdings, Inc. | 0.9615 |
| Natera, Inc. | 0.1309 |
| Myriad Genetics, Inc. | 0.6927 |
| Guardant Health, Inc. | -7.614 |
| Quest Diagnostics, Inc. | 0.8493 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.307B |
| Total Liabilities (Quarterly) | 2.641B |
| Shareholders Equity (Quarterly) | 665.65M |
| Current Ratio | 2.796 |
| Net Debt Paydown Yield | 0.31% |